ZIP11 (Solute Carrier Family 39 Member 11), encoded by the SLC39A11 gene, is a zinc importer belonging to the ZIP transporter family. In mice, it plays critical roles in gastrointestinal zinc homeostasis, nuclear zinc regulation, and maintainence of mucosal integrity . Recombinant mouse ZIP11 proteins are engineered versions of this transporter, typically produced in heterologous systems (e.g., E. coli) for functional and structural studies. These proteins are tagged (e.g., His-GST) to facilitate purification and analysis .
Note: Full-length mouse ZIP11 is not explicitly detailed in sources; human homolog data (e.g., MW, tags) are extrapolated for context.
ZIP11 exhibits tissue-specific expression patterns in mice:
Gastrointestinal Tract:
Nuclear Role: Colocalizes with nuclear fractions, regulating zinc homeostasis critical for transcriptional activity .
Zinc Restriction: Induces ZIP11 expression in the colon to enhance zinc absorption efficiency .
Nuclear Transport: Maintains nuclear zinc levels, essential for gene regulation and DNA repair. Knockdown in HeLa cells (human model) causes nuclear zinc accumulation, senescence, and impaired proliferation .
Cancer Studies: ZIP11’s nuclear zinc regulation is linked to carcinogenesis. Recombinant ZIP11 aids in modeling ovarian and cervical cancer progression .
Therapeutic Targeting: Inhibiting ZIP11 may disrupt nuclear zinc balance, offering a strategy to suppress metastasis .
Protein Engineering: Recombinant ZIP11 tagged with His-GST enables structural analysis (e.g., X-ray crystallography) and zinc transport assays .
Murine-Specific Studies: Limited data exist on recombinant mouse ZIP11. Future work should validate its structural and functional conservation with human homologs.
Pathological Roles: Investigate ZIP11’s involvement in gastrointestinal disorders (e.g., zinc deficiency) and reproductive health .
Therapeutic Development: Explore ZIP11 inhibitors to modulate nuclear zinc levels in cancers .
Mouse ZIP11 (Slc39a11) is the sole member of the gufA subfamily of ZIP transporters, exhibiting strong conservation across multiple species. It is located on the antisense strand of chromosome 11 in mice, while human ZIP11 is positioned on the antisense strand of chromosome 17 . This conservation suggests critical biological functions that have been maintained throughout evolution.
The ZIP11 promoter region contains multiple metal response elements (MREs) that allow for responsiveness to zinc availability, demonstrating an evolved regulatory mechanism for maintaining zinc homeostasis . When studying recombinant ZIP11, researchers should consider these evolutionary conserved regions in their experimental design to ensure proper expression and regulation.
ZIP11 demonstrates distinct tissue-specific expression patterns in mice, with highest expression observed in the gastrointestinal tract. Specifically, the stomach, cecum, and colon show the greatest ZIP11 expression levels . Within the stomach, ZIP11 is predominantly localized to gastric parietal cells and lower regions of the gastric glands. In the colon, ZIP11 is expressed in epithelial cells .
For researchers working with recombinant ZIP11, this tissue distribution knowledge is critical for selecting appropriate experimental models that reflect physiological relevance. Cellular models derived from gastric or colonic tissues would provide more physiologically relevant contexts for studying ZIP11 function compared to other cell types where expression is naturally lower.
ZIP11 expression demonstrates responsiveness to dietary zinc levels, particularly in the stomach. Research has shown that zinc restriction through a zinc-deficient diet (ZnD) decreases ZIP11 protein expression in the stomach, while subsequent zinc repletion (ZnR) can restore expression to levels comparable to those observed with adequate zinc (ZnA) diets .
Methodology for studying zinc-dependent regulation:
Subject experimental animals to zinc-adequate (ZnA), zinc-deficient (ZnD), and zinc-repletion (ZnR) diets
Confirm effectiveness of dietary intervention by measuring serum zinc levels
Extract tissues of interest (e.g., stomach, colon)
Perform Western blot analysis using ZIP11-specific antibodies
Quantify relative expression changes across dietary conditions
This zinc-responsive regulation highlights the importance of controlling zinc levels in experimental systems when working with recombinant ZIP11 to ensure consistent expression and function.
ZIP11 exhibits a complex subcellular distribution pattern. Unlike some zinc transporters that are strictly localized to the plasma membrane, ZIP11 has been detected in multiple cellular compartments. Specifically, ZIP11 is present in the cytoplasm, membrane, and nuclear fractions of mouse colon cells .
The nuclear localization is particularly significant as it suggests potential roles in regulating nuclear zinc levels, which can impact various nuclear processes including gene expression and DNA repair. For researchers developing recombinant ZIP11 constructs, consideration of subcellular targeting signals is essential to maintain proper localization.
| Subcellular Fraction | ZIP11 Detection | Control Protein |
|---|---|---|
| Cytoplasmic | Positive | Tubulin (positive) |
| Membrane | Positive | ZIP4 (positive) |
| Nuclear | Positive | TBP (positive) |
This distribution pattern contrasts with other zinc transporters like ZIP4, which is predominantly localized to the membrane fraction, highlighting the unique properties of ZIP11 .
Multiple complementary approaches are recommended for comprehensive analysis of recombinant ZIP11 function:
Expression Systems: HEK293T cells have been successfully used for transfection studies with ZIP11 constructs. These cells provide a reliable system for overexpression and functional analysis .
Knockdown Models: shRNA-mediated knockdown targeting the 3' UTR non-coding region has proven effective. Note that complete knockout of ZIP11 by CRISPR/Cas9 resulted in non-viable cells, suggesting essential functions .
Subcellular Fractionation: For studying localization, differential centrifugation to separate cytoplasmic, membrane, and nuclear fractions is recommended, with verification using compartment-specific marker proteins (tubulin, TBP) .
Zinc Transport Assays: Atomic absorption spectroscopy (AAS) of subcellular fractions can effectively measure zinc redistribution mediated by recombinant ZIP11 variants .
Functional Recovery Studies: Expressing recombinant wild-type or mutant ZIP11 in knockdown cells to assess restoration of function provides valuable insights into structure-function relationships .
Antibody Validation: Peptide competition assays should be employed to verify antibody specificity before immunodetection of recombinant ZIP11. The protein is typically detected at approximately 35 kDa .
The transmembrane region of ZIP11 contains three critical metal-binding sites (MBS) that are essential for zinc transport: H204, E208, and E244 . These residues are highly conserved and align with metal-binding residues identified in related zinc transporters like BbZIP4 from B. bronchiseptica.
Studies using site-directed mutagenesis to create H204A, E208A, and E244A mutations have revealed their differential contributions to ZIP11 function:
| Mutation | Expression Level | Nuclear Zinc Mobilization | Cell Proliferation | Zinc Resistance | Migration Restoration |
|---|---|---|---|---|---|
| H204A | Lower | Impaired | Impaired | ~20% of WT | Minimal |
| E208A | Lower | Impaired | Impaired | ~20% of WT | Minimal |
| E244A | Normal | Impaired | Partial (~40%) | ~50% of WT | Partial |
| Wild-type | Normal | Normal | Normal | Normal | Normal |
These findings indicate that H204 and E208 are critical for both protein stability and zinc transport function, while E244 may have a more specialized role in the transport mechanism . Researchers working with recombinant ZIP11 should consider these residues when designing constructs, particularly if the goal is to manipulate zinc transport activity.
ZIP11 has emerged as a significant factor in cancer cell biology, with particular relevance to ovarian and cervical cancers. Four single nucleotide polymorphisms (SNPs) in the SLC39A11 gene resulting in amino acid changes (A26S, A89V, A234P, and P243S) have been identified in ovarian cancer patients .
Functional studies using recombinant ZIP11 proteins with these mutations in ZIP11-knockdown HeLa cells have revealed their effects on cancer-related cellular behaviors:
| Mutation | Nuclear Zinc | Proliferation | Zinc Resistance | Migration | Invasion |
|---|---|---|---|---|---|
| A26S | Normalized | Restored | Complete (~100%) | Complete | Enhanced |
| A89V | Elevated | Restored | Minimal (~20%) | Minimal | Minimal |
| A234P | Normalized | Restored | Complete (~100%) | Complete | Enhanced |
| P243S | Normalized | Restored | Partial (~50%) | Partial | Enhanced |
Notably, the A234P and P243S mutations, which are located near the substrate-binding region, demonstrated the strongest effects on restoring cancer cell behaviors in ZIP11-knockdown cells. These findings suggest that these specific variants may contribute to cancer progression by enhancing zinc transport capabilities that support proliferation, migration, and invasion .
For researchers, these results underscore the importance of studying ZIP11 variants in cancer models and suggest potential therapeutic targets focused on these specific residues.
ZIP11 plays a critical role in regulating nuclear zinc levels. Knockdown of SLC39A11 results in significant nuclear zinc accumulation (approximately double the concentration compared to wild-type cells), indicating that ZIP11 is essential for mobilizing zinc from the nucleus .
This nuclear zinc accumulation in ZIP11-deficient cells correlates with impaired proliferation, migration, and invasion capabilities, and the development of a senescent cellular state . These phenotypes can be rescued by reintroducing wild-type ZIP11, confirming the direct relationship between ZIP11-mediated nuclear zinc homeostasis and cellular functions.
Mechanisms proposed for ZIP11's nuclear zinc regulation:
Direct transport of zinc from the nucleus to the cytoplasm
Indirect effects through signaling pathways that influence nuclear zinc importers/exporters
Sequestration of zinc in specific nuclear compartments
For researchers working with recombinant ZIP11, nuclear localization signals and zinc-binding domains should be preserved to maintain this critical function in experimental systems.
When analyzing the functional impacts of ZIP11 mutations, a comprehensive methodological approach should include:
Structural Analysis:
Expression Analysis:
Western blotting to confirm expression levels of mutant proteins
Immunofluorescence to verify subcellular localization
Zinc Transport Assessment:
Functional Assays:
Control Considerations:
Include wild-type ZIP11, empty vector, and untransfected controls
Use specific inhibitors (e.g., AraC) to distinguish migration from proliferation effects
Validate knockdown efficiency before rescue experiments
This methodological framework provides a robust approach for characterizing the functional consequences of ZIP11 mutations in research settings.
When designing experiments with recombinant mouse ZIP11, appropriate controls are essential for reliable interpretation:
Antibody Specificity Controls:
Subcellular Fractionation Controls:
Functional Rescue Controls:
Zinc Treatment Controls:
Researchers should systematically incorporate these controls to ensure reliable interpretation of recombinant ZIP11 function in experimental systems.
Understanding the structure-function relationship of ZIP11 requires a multifaceted approach:
Sequence Alignment and Conservation Analysis:
Homology Modeling:
Structure-Guided Mutagenesis:
Functional Correlation Studies:
This integrated approach allows researchers to develop refined models of how specific structural elements of ZIP11 contribute to its zinc transport function and cellular roles.
ZIP11 research has significant implications for understanding cancer biology, particularly in ovarian and cervical cancers:
Altered Expression Patterns:
Functional Impact of SNPs:
Zinc Homeostasis Mechanism:
Therapeutic Potential:
ZIP11 and its signaling pathways represent potential therapeutic targets
Modulating zinc distribution through targeting specific ZIP11 domains could inhibit cancer progression
The differential effects of specific mutations provide opportunities for personalized approaches
Researchers investigating recombinant ZIP11 should consider these cancer-related aspects, particularly when designing experiments to evaluate therapeutic strategies targeting zinc transport mechanisms.
Recombinant ZIP11 provides a versatile tool for investigating zinc-dependent cellular processes:
Nuclear Zinc Regulation:
Senescence and Cell Cycle Regulation:
Migration and Invasion Mechanisms:
Differential Tissue Responses to Zinc:
These applications position recombinant ZIP11 as a valuable research tool for exploring fundamental zinc biology and potential therapeutic interventions in zinc-related disorders.